Invesco
RVLP

Invesco’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Invesco’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,486
Closed -$34K – 4062
2021
Q1 		$34K Buy
10,486
+334
+3% +$1.37K ﹤0.01% 3844
2020
Q4 		$42K Buy
+10,152
New +$58.5K ﹤0.01% 3751

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco's RVLP Position: Q2 2021 in Review

Invesco sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 10,486 shares — an estimated $34K sold.

Invesco first reported a position in RVLP in Q4 2020 and held it in 2 quarters. The position peaked at $42K in Q4 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Invesco reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 10,486 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $34K.
  • Invesco first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2020 and held it in 2 quarters.
  • Invesco's RVL Pharmaceuticals plc Ordinary Shares position peaked at $42K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.